Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Ondine Biomed (OBI)

Price 12.00p on 14-02-2025 at 17:30:02
Change -0.25p -2.04%
Buy 12.50p
Sell 11.50p
Buy / Sell OBI Shares
Last Trade: Sell 250.00 at 11.50p
Day's Volume: 84,980
Last Close: 12.00p
Open: 12.25p
ISIN: CA68234M2058
Day's Range 12.00p - 12.25p
52wk Range: 5.125p - 13.30p
Market Capitalisation: £53m
VWAP: 11.997p
Shares in Issue: 442m

Recent Trades History Ondine Biomed (OBI)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 250 11.50p Ordinary
16:07:24 - 14-Feb-25
Sell* 392 11.651p Ordinary
16:04:15 - 14-Feb-25
Sell* 14,000 11.651p Ordinary
15:50:09 - 14-Feb-25
Buy* 8,780 12.05p Ordinary
14:58:18 - 14-Feb-25
Unknown* 25,000 12.00p Ordinary
14:53:41 - 14-Feb-25
Sell* 1,000 12.01p Ordinary
14:47:45 - 14-Feb-25
Buy* 2,400 12.50p SI Trade
13:32:10 - 14-Feb-25
Sell* 24,943 12.0275p Ordinary
13:32:02 - 14-Feb-25
Sell* 95 12.00p Ordinary
09:58:21 - 14-Feb-25
Buy* 8,120 12.315p Ordinary
08:04:22 - 14-Feb-25

Share Price History for Ondine Biomed

Time period:
to
Date Open High Low Close Volume

Share News for Ondine Biomed

Ondine Biomedical shares slide as funding continues to be delayed

27th Jan 2025 11:04

(Alliance News) - Ondine Biomedical Inc on Monday said it expects its cash to last until the beginning of the fourth-quarter as it reported an equity investment from a leading US healthcare provider. Read More

AIM WINNERS & LOSERS: hVIVO wins deal; Good Energy backs buyout

27th Jan 2025 10:04

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday. Read More

LONDON MARKET MIDDAY: Uninspiring trade as no Santa rally for FTSE 100

30th Dec 2024 12:05

(Alliance News) - London's FTSE 100 was in the red midday Monday, eating into a year-to-date gain that already pales in comparison to counterparts state side. Read More

AIM WINNERS & LOSERS: Ondine Biomedical rises, Proton Power declines

30th Dec 2024 11:01

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday. Read More

Ondine Biomedical reports "exciting milestone" in US phase 3 trial

30th Dec 2024 09:51

(Alliance News) - Ondine Biomedical Inc on Monday said it has recruited and treated the first patient in its phase 3 clinical trial evaluating its non-antibiotic nasal photodisinfection technology. Read More

FTSE 100 Latest
Value8,732.46
Change-32.26

Login to your account

Forgot Password?

Not Registered